ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Austin J. Stuckert et al.|Cancer Discovery|2021Cited by 90
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinaseXiaoyong Fu, Rachel Schiff, Chad J. Creighton et al.|Breast Cancer Research|2014Cited by 70
Table S1 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Yanhua Zhao et al.|Unknown|2023Cited by 0